InvestorPlace - Stock Market News, Stock Advice & Trading Tips
KNSA stock results show that Kiniksa Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
The post KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace